Pathology Department, "IASO" Women's Hospital, Maroussi, Greece
Pathology Department, "IASO" Women's Hospital, Maroussi, Greece.
Int J Gynecol Cancer. 2019 Mar;29(3):572-578. doi: 10.1136/ijgc-2018-000086. Epub 2019 Jan 18.
To compare distinct clinicopathological features between atypical proliferative serous tumors and non-invasive low-grade ovarian serous carcinomas.
Our study group comprised 203 cases of serous borderline tumors sub-classified as atypical proliferative serous tumors or as non-invasive low-grade serous carcinomas. All pathological features related to borderline tumors were re-evaluated by two gynecological pathologists. Data concerning recurrences and survival were retrieved from the medical records of the patients.
When comparing atypical proliferative serous tumors to non-invasive low-grade serous carcinomas, the latter were statistically related to advanced stage at diagnosis, bilateral disease, exophytic pattern of growth, microinvasive carcinoma, and the presence of invasive implants. In univariate analysis, recurrences were statistically related to the exophytic pattern of growth, to microinvasion, and to the presence of implants (both invasive and non-invasive). Nevertheless, in multivariate analysis, only microinvasion and the presence of invasive implants were related to recurrence. Women who eventually succumbed to the disease were only those with invasive implants. Their ovarian tumor was either a non-invasive low-grade serous carcinoma or an atypical proliferative serous tumor with 'minimal' micropapillary pattern. Neither lymph node involvement nor endosalpingiosis seemed to influence the course of the disease.
The results of our study underline the increased possibility of non-invasive low-grade serous carcinomas to be related with features indicative of aggressive behavior as opposed to atypical proliferative serous tumors. Nevertheless, irrespective of tumor histology, the presence of invasive implants and microinvasion were the only independent prognostications of recurrence.
比较非典型增生性浆液性肿瘤和非浸润性低级别卵巢浆液性癌之间的不同临床病理特征。
我们的研究组包括 203 例浆液性交界性肿瘤,分为非典型增生性浆液性肿瘤或非浸润性低级别浆液性癌。由两位妇科病理学家重新评估与交界性肿瘤相关的所有病理特征。从患者的病历中检索有关复发和生存的数据。
当将非典型增生性浆液性肿瘤与非浸润性低级别浆液性癌进行比较时,后者在统计学上与诊断时的晚期、双侧疾病、外生性生长模式、微浸润癌以及存在浸润性种植体有关。在单因素分析中,复发与外生性生长模式、微浸润和种植体(浸润性和非浸润性)的存在在统计学上相关。然而,在多因素分析中,只有微浸润和浸润性种植体的存在与复发有关。最终死于该疾病的女性仅为存在浸润性种植体的患者。她们的卵巢肿瘤要么是非浸润性低级别浆液性癌,要么是具有“最小”微乳头状模式的非典型增生性浆液性肿瘤。淋巴结受累和内胚层异位均似乎不影响疾病的进程。
我们的研究结果强调了非浸润性低级别浆液性癌更有可能与侵袭性行为相关的特征,而非非典型增生性浆液性肿瘤。然而,无论肿瘤组织学如何,浸润性种植体和微浸润的存在是复发的唯一独立预后因素。